Merck hit with fine from antitrust regulator; pharma companies invest in online prescribing

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: Merck fined $39 million by Spain's antitrust regulator for 'serious' violation By Ed Silverman Kena Betancur/Getty Images The regulator chided Merck for a “lack of transparency” and “conduct contrary to merit-based competition.” Read More STAT+: Pharma companies are investing in online prescribing. Who's keeping watch? By Katie Palmer Adobe Pharma companies are building "talk to a doctor now" buttons into drug websites. But the new model of care falls into a regulatory gray area. Read More STAT+: Normunity launches with $65 million to unleash the immune system on tumors By Ryan Cross — The Boston Globe Normunity The Boston biotech startup, which has raised $65 million, is based on the research of Yale immunologist Lieping Chen. Read More Sponsored Insight by Salix Raising awareness for liver disease prevention and care for patients With Liver Awareness Month this October, a Salix-sponsored Liver Health Annual Trends Report, a second edition market research survey highlights findings on barriers to quality care for chronic liver disease (CLD) and cirrhosis patients, and associated complications including hepatic encephalopathy (HE). Salix also raises awareness of a new ICD-10 code from CMS for HE. Check out the full article here. Got questions about the timing of flu and Covid vaccines? Here's what experts say By Megan Molteni Adobe There are subtle questions of timing that scientists are still investigating, including whether time of day or combining vaccines matters. Read More Tuesday, October 25, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser